Trial
NCT02317276
A Study to Determine Serum and Skin Biopsy Biomarkers in Patients Receiving Topical Corticosteroid (TCS) and Following TCS Withdrawal
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of California, San Francisco
Collaborators
Genentech, Inc.
Condition
Dermatitis, Atopic
Intervention
Triamcinolone 0.1%
Why stopped
Unable to meet the study's recruitment goals
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-01-24